Macular edema secondary to retinal vein occlusion
Showing 1 - 25 of >10,000
Central Retinal Vein Occlusion With Macular Edema Trial in Peshawar (Group A)
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Group A
-
Peshawar, KPK, PakistanHayatabad Medical Complex
Apr 3, 2022
Branch Retinal Vein Occlusion, Ranibizumab, Laser Photocoagulation Trial in Beijing (Ranibizumab combined macular laser,
Completed
- Branch Retinal Vein Occlusion
- +2 more
- Ranibizumab combined macular laser
- Ranibizumab
-
Beijing, Beijing, ChinaBeijing Hospital
Dec 25, 2022
Retinal Vein Occlusion Trial in Damietta (Triamcinolone Acetonide)
Completed
- Retinal Vein Occlusion
- Triamcinolone Acetonide
-
Damietta, EgyptAkram Fekry Elgazzar
Apr 21, 2022
Intravitreal Aflibercept in Diabetic Macular Edema and/or
Completed
- Macular Edema
- Aflibercept (Eylea, BAY86-5321)
-
Multiple Locations, China
- +10 more
Nov 10, 2022
Macula Edema Trial in Damieta (Triamcinolone Acetonide and sodium hyaluronate and chondroitin sulfate, Triamcinolone Acetonide
Completed
- Macula Edema
- Triamcinolone Acetonide and sodium hyaluronate and chondroitin sulfate
- Triamcinolone Acetonide alone
-
Damieta, New Damietta, EgyptEhab tharwat
May 21, 2022
Non-Ischemic Central Retinal Vein Occlusion With Macular Edema Trial in Qina (intravitreal injection of Ranibizumab,
Recruiting
- Non-Ischemic Central Retinal Vein Occlusion With Macular Edema
- intravitreal injection of Ranibizumab
- +3 more
-
Qinā, Qena, EgyptAhmed Ali Ahmed Amer
Mar 15, 2022
Use of Aflibercept Injections Into Eye for Treatment of Eye
Recruiting
- Retinal Disease
- Aflibercept (BAY86-5321, Eylea)
-
Multiple Locations, MexicoMany locations
Aug 22, 2022
Macular Edema Trial in Tehran (intravitreal injection of bevacizumab with acetazolamide tablets, intravitreal injection of
Active, not recruiting
- Macular Edema
- intravitreal injection of bevacizumab with acetazolamide tablets
- intravitreal injection of bevacizumab
-
Tehran, Iran, Islamic Republic ofOphthalmic Research center
Mar 12, 2022
Artificial Intelligence Diagnostic Aid
Not yet recruiting
- Wet Macular Degeneration
- +2 more
- Macusense Assessment Software
-
London, Westminster, United KingdomGuy's and St Thomas's NHS Foundation Trust
Dec 29, 2022
Branch Retinal Vein Occlusion Trial in Worldwide (Brolucizumab 6 mg, Aflibercept 2 mg, Sham injection)
Terminated
- Branch Retinal Vein Occlusion
- Brolucizumab 6 mg
- +2 more
-
Phoenix, Arizona
- +101 more
Jan 27, 2023
Macular Edema, Retinal Vein Occlusion Trial in Assiut (Intravitreal injection of Dexamethasone implant)
Recruiting
- Macular Edema
- Retinal Vein Occlusion
- Intravitreal injection of Dexamethasone implant
-
Assiut, EgyptFaculty of medicine
Feb 27, 2022
Retinal Vein Occlusion, Diabetic Macular Edema Trial in Beverly Hills, Boston (KPI-121 0.25% Ophthalmic Suspension, KPI-121 1.0%
Completed
- Retinal Vein Occlusion
- Diabetic Macular Edema
- KPI-121 0.25% Ophthalmic Suspension
- KPI-121 1.0% Ophthalmic Suspension
-
Beverly Hills, California
- +1 more
Dec 9, 2020
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- BD311
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Aug 22, 2022
Branch Retinal Vein Occlusion Trial in BeiJing (601 1.25mg, Ranibizuman 0.5 mg)
Not yet recruiting
- Branch Retinal Vein Occlusion
- 601 1.25mg
- Ranibizuman 0.5 mg
-
BeiJing, Beijing, ChinaBeiJing Hospital
Dec 8, 2020
Central Retinal Vein Occlusion Trial in TianJing (601 1.25mg, Ranibizuman 0.5 mg)
Not yet recruiting
- Central Retinal Vein Occlusion
- 601 1.25mg
- Ranibizuman 0.5 mg
-
TianJing, TianJing, ChinaTianJing Medical University Eye Hospital
Dec 8, 2020
Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)
Completed
- Diabetic Macular Edema
- Retina Vein Occlusion
-
Phoenix, Arizona
- +5 more
Nov 18, 2021
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (KSI-301, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Retinal Vein Occlusion
- KSI-301
- +2 more
-
Phoenix, Arizona
- +140 more
Jul 20, 2022
Branch Retinal Vein Occlusion, Macular Edema Trial in Odense, Roskilde (Aflibercept Injection [Eylea], Navigated laser
Completed
- Branch Retinal Vein Occlusion
- Macular Edema
- Aflibercept Injection [Eylea]
- Navigated laser photocoagulation
-
Odense, Danmark, Denmark
- +1 more
Apr 18, 2022
Central Retinal Vein Occlusion With Macular Edema, Branch Retinal Vein Occlusion With Macular Edema Trial in Taiwan (TLC399)
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Branch Retinal Vein Occlusion With Macular Edema
-
Chang Hua, Taiwan
- +5 more
Nov 24, 2021
Functional Optical Coherence Tomography for Ocular Imaging
Completed
- Glaucoma
- +4 more
- Optical Coherence Tomography
-
Irvine, CaliforniaBeckman Laser Institute, University of California,Irvine
Oct 19, 2022
Macular Edema, Branch Retinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Branch Retinal Vein Occlusion
- Faricimab
- +2 more
-
Phoenix, Arizona
- +151 more
Aug 4, 2022
Retinal Vein Occlusion, Diabetic Macular Edema, Branch Retinal Vein Occlusion Trial in Cleveland (Aflibercept)
Completed
- Retinal Vein Occlusion
- +3 more
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
May 10, 2021
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative
Completed
- Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)
- +6 more
- Refresh Plus Preservative-free Lubricant Eye Drops
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics - Department of Ophthalmo
Apr 16, 2023